StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$0.94−0.07 (-6.72%)

Close on Nov 18, 2026Market cap $164.18MP/E –Yield –

Palisade Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Palisade Bio's market cap was $203.11M on Nov 11, 2026, against $19.24M a year earlier. Over the last 5 years it ranged from $1.63M to $354.93M, with a median of $5.76M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$203.11M+847.8%
2025Dec 31, 2025$21.43M+983.7%
2024Dec 31, 2024$1.98M-63.6%
2023Dec 29, 2023$5.43M-32.2%
2022Dec 30, 2022$8.02M-52.3%
2021Dec 31, 2021$16.81M-81.6%
2020Dec 31, 2020$91.32M+445.5%
2019Dec 31, 2019$16.74M-41.4%
2018Dec 31, 2018$28.57M-81.7%
2017Dec 29, 2017$156.34M-17.0%
2016Dec 30, 2016$188.40M-66.8%
2015Dec 31, 2015$567.60M-60.1%
2014Dec 31, 2014$1.42B+6.3%
2013Dec 31, 2013$1.34B+200.6%
2012Dec 31, 2012$445.08M+56.9%
2011Dec 30, 2011$283.73M–

More Palisade Bio figures

See a number that looks wrong?